Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
December 2025: Emcure Pharmaceuticals launched Poviztra, a semaglutide-based weight-loss therapy, at USD 106 (INR 8,790) per month, becoming the first Indian company to commercialize Novo Nordisks molecule for obesity
NAC deacetylates under the action of N-deacetylase to enhance intracellular Cys, thereby increasing the endogenous synthesis of GSH
Sistema cardiovascular : Mantener unos niveles adecuados de testosterona ayuda a mantener a raya los triglicridos y, por tanto, ayudar a frenar la hipercolesterolemia
Patients range in age from 4 to 98 years (mean 43,7), showing predilection for females (1,9:1)
US$ 21.36
US$ 23.30
US$ 20.12
US$ 25.89
US$ 21.78
